Legal Representation
Attorney
Katrin Lewertoff and Peter J. Toren
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 30, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 30, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 19, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 27, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 7, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 30, 2006 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 30, 2006 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 8, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 5, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 28, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 27, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 5, 2006 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Oct 4, 2005 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 29, 2005 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Nov 17, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 10, 2004 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 18, 2004 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 13, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 13, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 19, 2003 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 19, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular disease and diabetes, including high blood pressure, congestive heart failure, atherosclerosis, hypercholesteremia, hyperlipidemia, stroke and diabetic nephropathy
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005